Report overview
The cell and gene therapy isolator integrates cell culture-related functional components such as centrifuges and CO2 incubators, and completes cell culture-related operations in a closed and sterile environment to meet GMP production requirements for cell products.
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Isolator, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Isolator. This report contains market size and forecasts of Cell and Gene Therapy Isolator in global, including the following market information:
Global Cell and Gene Therapy Isolator Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Cell and Gene Therapy Isolator Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Cell and Gene Therapy Isolator companies in 2022 (%)
The global Cell and Gene Therapy Isolator market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Mobile Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cell and Gene Therapy Isolator include Skan Holding, Netsteril, Comecer, Esco Pharma, Extract Technology, Tema Sinergie, Optima Pharma, Bioquell and BioSpherix, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cell and Gene Therapy Isolator manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell and Gene Therapy Isolator Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Cell and Gene Therapy Isolator Market Segment Percentages, by Type, 2022 (%)
Mobile
Floor-standing
Global Cell and Gene Therapy Isolator Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Cell and Gene Therapy Isolator Market Segment Percentages, by Application, 2022 (%)
Medicine
Laboratory
Others
Global Cell and Gene Therapy Isolator Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Cell and Gene Therapy Isolator Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell and Gene Therapy Isolator revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cell and Gene Therapy Isolator revenues share in global market, 2022 (%)
Key companies Cell and Gene Therapy Isolator sales in global market, 2018-2023 (Estimated), (Units)
Key companies Cell and Gene Therapy Isolator sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Skan Holding
Netsteril
Comecer
Esco Pharma
Extract Technology
Tema Sinergie
Optima Pharma
Bioquell
BioSpherix
Germfree
Lonza
Sony
BioAir
Ecolab
ZheJiang Tailin Bioengineering
JCE Biotechnology
Euroclone
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cell and Gene Therapy Isolator, market overview.
Chapter 2: Global Cell and Gene Therapy Isolator market size in revenue and volume.
Chapter 3: Detailed analysis of Cell and Gene Therapy Isolator manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cell and Gene Therapy Isolator in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cell and Gene Therapy Isolator capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
